$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Hedge Funds Standing By Corcept Therapeutics Incorporated (CORT)
01:40pm, Friday, 19'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Deutsche Bank AG Buys 821,578 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)
08:16am, Thursday, 18'th Jun 2020
Deutsche Bank AG grew its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) by 1,325.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securiti
Corcept Therapeutics to Present Data at the American Association of Cancer Research Annual Meeting
12:30pm, Monday, 15'th Jun 2020
Corcept Therapeutics Incorporated (CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the
7 Great Biotech Stocks to Buy and Hold Now
02:55pm, Thursday, 11'th Jun 2020
As investors begin to turn their attention away from Covid-19 and the novel coronavirus, these biotech stocks present excellent opportunities.
State Street Corp Buys 147,082 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)
05:08am, Wednesday, 10'th Jun 2020
State Street Corp raised its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) by 4.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Sec
Edited Transcript of CORT earnings conference call or presentation 4-May-20 9:00pm GMT
03:24am, Tuesday, 09'th Jun 2020
Q1 2020 Corcept Therapeutics Inc Earnings Call
CMS Approves SINUVA® Sinus Implant for Reimbursement with New C-Code and Pass-Through Payment Status
12:00am, Tuesday, 09'th Jun 2020
Intersect ENT®, Inc. (Nasdaq: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that
Has Corcept Therapeutics (CORT) Outpaced Other Medical Stocks This Year?
03:30pm, Wednesday, 03'rd Jun 2020
Is (CORT) Outperforming Other Medical Stocks This Year?
These 4 Biotech Stocks Are Outperforming Their Peers — Here's Why
02:00pm, Tuesday, 02'nd Jun 2020
The best biotech companies to invest in tend to have a commonality: a strong streak of earnings growth.
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q1 2020 Earnings Call Transcript | AlphaStreet
05:31pm, Tuesday, 19'th May 2020
Final earnings conference call transcript of Corcept Therapeutics Inc. - CORT stock
Should You Worry About Corcept Therapeutics Incorporated's (NASDAQ:CORT) CEO Pay?
10:23am, Monday, 18'th May 2020
Joseph Belanoff has been the CEO of Corcept Therapeutics Incorporated (NASDAQ:CORT) since 1999. This report will...
Corcept Therapeutics to Present Data at the American Society of Clinical Oncology Annual Meeting
08:05pm, Thursday, 14'th May 2020
Corcept Therapeutics Incorporated (CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the
6 Stocks John Hussman Continues to Buy
05:16pm, Wednesday, 13'th May 2020
AT&T; makes the list Continue reading...
Should You Climb on Board the Corcept Therapeutics Train?
11:45am, Tuesday, 12'th May 2020
Corcept Therapeutics Inc. (NASDAQ: CORT) continues to make its investors happy. The Menlo Park, Calif., biotech company beat earnings estimates in its first-quarter report last week. While the effe
Sign In
Buy CORT